OBN Investment & Tax Special Interest Group (ITSIG)

The OBN Investment & Tax Special Interest Group (ITSIG) works to get the voice of OBN Members heard in the national and local political arena in an effort to create a more favourable fiscal environment for emerging, small and medium sized enterprises in the life sciences industry from UK and European Governments.

Download the Group Objectives document here.

The ITSIG Team

Chair:

Shawn Manning, Managing Director, Akesios Associates Limited

Members:

John Harris, CEO, OBN

Bill Fleming, CFO, Oxitec Ltd

Matthew Frohn, Partner, Longwall Ventures

Huw Jones, CEO, Chronos Therapeutics

Howard Sherman, CFO, Safeguard Biosystems Holdings Ltd

Mark White, Director, Midven

Mike Shearan, Senior Manager, James Cowper Kreston